• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西妥昔单抗与口腔癌NOTCH信号通路靶点的分子对接分析

Molecular docking analysis of cetuximab with NOTCH signalling pathway targets for oral cancer.

作者信息

Pazhani Jayanthi, Veeraraghavan Vishnu Priya, Jayaraman Selvaraj

机构信息

Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600077, India.

出版信息

Bioinformation. 2023 Apr 30;19(4):471-473. doi: 10.6026/97320630019471. eCollection 2023.

DOI:10.6026/97320630019471
PMID:37822809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10563571/
Abstract

Notch signaling is an evolutionarily ancient mechanism which intricated in cell-cell communication and it plays a crucial role in various developments in malignancies. Inactivating mutations of NOTCH targets are present in about 10 % of cases of squamous cell carcinoma of the skin, oral cavity, and esophagus that rendering it one of the most frequently mutated genes in oral squamous cell carcinoma. Therefore, it is of interest to document the molecular docking analysis of cetuximab with the NOTCH signaling targets such as NOTCH1, NICD, and HES1. These results suggest that targeting the NOTCH signaling with cetuximab might leads to the better outcome for suppression of invasion and metastasis in oral carcinoma.

摘要

Notch信号通路是一种进化上古老的机制,它参与细胞间通讯,在恶性肿瘤的各种发展过程中起着关键作用。NOTCH靶点的失活突变存在于约10%的皮肤、口腔和食管鳞状细胞癌病例中,这使其成为口腔鳞状细胞癌中最常发生突变的基因之一。因此,记录西妥昔单抗与NOTCH信号靶点(如NOTCH1、NICD和HES1)的分子对接分析很有意义。这些结果表明,用西妥昔单抗靶向NOTCH信号通路可能会为抑制口腔癌的侵袭和转移带来更好的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/10563571/4413985da79e/97320630019471F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/10563571/4413985da79e/97320630019471F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ef8/10563571/4413985da79e/97320630019471F1.jpg

相似文献

1
Molecular docking analysis of cetuximab with NOTCH signalling pathway targets for oral cancer.西妥昔单抗与口腔癌NOTCH信号通路靶点的分子对接分析
Bioinformation. 2023 Apr 30;19(4):471-473. doi: 10.6026/97320630019471. eCollection 2023.
2
Notch signaling in oral squamous neoplasia.口腔鳞状肿瘤中的Notch信号通路
Pathol Int. 2016 Nov;66(11):609-617. doi: 10.1111/pin.12461. Epub 2016 Sep 26.
3
The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.头颈部鳞状细胞癌中的Notch信号通路:一项荟萃分析。
Adv Clin Exp Med. 2017 Aug;26(5):881-887. doi: 10.17219/acem/64000.
4
Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.Notch 信号通路的激活与口腔鳞状细胞癌患者的死亡率增加及 FGFR1 介导的侵袭相关。
Mol Cancer Res. 2016 Sep;14(9):883-91. doi: 10.1158/1541-7786.MCR-16-0114. Epub 2016 Jun 27.
5
Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma.Notch 信号通路:口腔鳞状细胞癌潜在的治疗途径。
Endocr Metab Immune Disord Drug Targets. 2021;21(12):2159-2168. doi: 10.2174/1871530321666210421125231.
6
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma. Notch 信号对头颈部鳞状细胞癌患者预后的影响。
Oral Oncol. 2020 Nov;110:105003. doi: 10.1016/j.oraloncology.2020.105003. Epub 2020 Sep 12.
7
The pathological significance of Notch1 in oral squamous cell carcinoma.Notch1 在口腔鳞状细胞癌中的病理意义。
Lab Invest. 2013 Oct;93(10):1068-81. doi: 10.1038/labinvest.2013.95. Epub 2013 Aug 12.
8
Molecular docking analysis of proflavin with the Wnt pathway targets for OSCC.原黄素与口腔鳞状细胞癌Wnt信号通路靶点的分子对接分析
Bioinformation. 2023 Apr 30;19(4):464-466. doi: 10.6026/97320630019464. eCollection 2023.
9
Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.Notch配体JAG1是祖细胞中经典WNT信号通路在进化上保守的靶点。
Int J Mol Med. 2006 Apr;17(4):681-5.
10
Notch activation leads to loss of myoepithelial differentiation and poor outcome in solid adenoid cystic carcinoma.Notch 激活导致实体腺样囊性癌中肌上皮分化丢失和预后不良。
Oral Dis. 2020 Nov;26(8):1677-1686. doi: 10.1111/odi.13480. Epub 2020 Jul 14.

引用本文的文献

1
Notch1 and CyclinD1 expression and significance in jaw ameloblastoma: an immunohistochemical analysis.Notch1和细胞周期蛋白D1在颌骨成釉细胞瘤中的表达及意义:一项免疫组织化学分析
Discov Oncol. 2025 Jul 25;16(1):1408. doi: 10.1007/s12672-025-03252-1.
2
Cancer-wide in silico analyses using differentially expressed genes demonstrate the functions and clinical relevance of JAG, DLL, and NOTCH.使用差异表达基因进行全癌症范围内的计算机分析,证明了 JAG、DLL 和 NOTCH 的功能和临床相关性。
PLoS One. 2024 Jul 29;19(7):e0307943. doi: 10.1371/journal.pone.0307943. eCollection 2024.
3
Suppression of Migration and Invasion by 4-Carbomethoxyl-10-Epigyrosanoldie E from the Cultured Soft Coral through the MAPKs Pathway on Oral Cancer Cells.

本文引用的文献

1
Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.Sox11 通过调控 SDCCAG8 促进头颈部癌症的进展。
J Exp Clin Cancer Res. 2019 Mar 29;38(1):138. doi: 10.1186/s13046-019-1146-7.
2
Cell-Cell Contact Area Affects Notch Signaling and Notch-Dependent Patterning.细胞间接触区域影响Notch信号传导和Notch依赖性模式形成。
Dev Cell. 2017 Mar 13;40(5):505-511.e6. doi: 10.1016/j.devcel.2017.02.009.
3
Clinicopathological analysis of 502 patients with oral squamous cell carcinoma with special interest to distant metastasis.
来自培养软珊瑚的4-甲氧羰基-10-表海松二萜E通过MAPKs信号通路抑制口腔癌细胞的迁移和侵袭
Adv Pharmacol Pharm Sci. 2024 Feb 12;2024:6695837. doi: 10.1155/2024/6695837. eCollection 2024.
502例口腔鳞状细胞癌患者的临床病理分析,特别关注远处转移情况。
Tokai J Exp Clin Med. 2014 Dec 20;39(4):178-85.
4
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
5
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
6
Treatment of recurrent metastatic head and neck cancer: focus on cetuximab.复发性转移性头颈癌的治疗:聚焦西妥昔单抗
Clin Med Insights Ear Nose Throat. 2012 Apr 3;5:1-16. doi: 10.4137/CMENT.S5129.
7
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.优化抗 EGFR 抗体治疗转移性结直肠癌患者:克服癌细胞耐药机制。
Expert Opin Biol Ther. 2013 Feb;13(2):241-55. doi: 10.1517/14712598.2012.756469. Epub 2013 Jan 3.
8
Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications.磁性纳米颗粒:设计与表征、毒性与生物相容性、药物及生物医学应用
Chem Rev. 2012 Nov 14;112(11):5818-78. doi: 10.1021/cr300068p. Epub 2012 Oct 9.
9
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.头颈部复发和/或转移性鳞状细胞癌患者一线治疗中厄洛替尼联合每周紫杉醇的 II 期研究。
Ann Oncol. 2012 Apr;23(4):1016-22. doi: 10.1093/annonc/mdr367. Epub 2011 Aug 23.
10
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.放疗联合西妥昔单抗治疗头颈部鳞状细胞癌。
N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422.